FDA — authorised 12 June 1941
- Application: NDA003977
- Marketing authorisation holder: PARKEDALE
- Local brand name: THEELIN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Estron in United States
FDA authorised Estron on 12 June 1941
Marketing authorisations
FDA — authorised 21 February 1979
- Marketing authorisation holder: WATSON LABS
- Status: approved
FDA
- Application: ANDA083397
- Marketing authorisation holder: WATSON LABS
- Local brand name: ESTRONE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA083488
- Marketing authorisation holder: WYETH AYERST
- Local brand name: ESTROGENIC SUBSTANCE
- Indication: INJECTABLE — INJECTION
- Status: approved
Estron in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Dermatology approved in United States
Frequently asked questions
Is Estron approved in United States?
Yes. FDA authorised it on 12 June 1941; FDA authorised it on 21 February 1979; FDA has authorised it.
Who is the marketing authorisation holder for Estron in United States?
PARKEDALE holds the US marketing authorisation.